Angiotensinogen and Megalin Interactions Contribute to Atherosclerosis—Brief Report
OBJECTIVE—AGT (Angiotensinogen) is the unique precursor of the renin-angiotensin system that is sequentially cleaved by renin and ACE (angiotensin-converting enzyme) to produce Ang II (angiotensin II). In this study, we determined how these renin-angiotensin components interact with megalin in kidne...
Saved in:
Published in | Arteriosclerosis, thrombosis, and vascular biology Vol. 39; no. 2; pp. 150 - 155 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Heart Association, Inc
01.02.2019
|
Subjects | |
Online Access | Get full text |
ISSN | 1079-5642 1524-4636 1524-4636 |
DOI | 10.1161/ATVBAHA.118.311817 |
Cover
Abstract | OBJECTIVE—AGT (Angiotensinogen) is the unique precursor of the renin-angiotensin system that is sequentially cleaved by renin and ACE (angiotensin-converting enzyme) to produce Ang II (angiotensin II). In this study, we determined how these renin-angiotensin components interact with megalin in kidney to promote atherosclerosis.
APPROACH AND RESULTS—AGT, renin, ACE, and megalin were present in the renal proximal convoluted tubules of wild-type mice. Hepatocyte-specific AGT deficiency abolished AGT protein accumulation in proximal tubules and diminished Ang II concentrations in kidney, while renin was increased. Megalin was most abundant in kidney and exclusively present on the apical side of proximal tubules. Inhibition of megalin by antisense oligonucleotides (ASOs) led to ablation of AGT and renin proteins in proximal tubules, while leading to striking increases of urine AGT and renin concentrations, and 70% reduction of renal Ang II concentrations. However, plasma Ang II concentrations were unaffected. To determine whether AGT and megalin interaction contributes to atherosclerosis, we used both male and female low-density lipoprotein receptor mice fed a saturated fat-enriched diet and administered vehicles (PBS or control ASO) or megalin ASO. Inhibition of megalin did not affect plasma cholesterol concentrations, but profoundly reduced atherosclerotic lesion size in both male and female mice.
CONCLUSIONS—These results reveal a regulatory role of megalin in the intrarenal renin-angiotensin homeostasis and atherogenesis, positing renal Ang II to be an important contributor to atherosclerosis that is mediated through AGT and megalin interactions. |
---|---|
AbstractList | Objective- AGT (Angiotensinogen) is the unique precursor of the renin-angiotensin system that is sequentially cleaved by renin and ACE (angiotensin-converting enzyme) to produce Ang II (angiotensin II). In this study, we determined how these renin-angiotensin components interact with megalin in kidney to promote atherosclerosis. Approach and Results- AGT, renin, ACE, and megalin were present in the renal proximal convoluted tubules of wild-type mice. Hepatocyte-specific AGT deficiency abolished AGT protein accumulation in proximal tubules and diminished Ang II concentrations in kidney, while renin was increased. Megalin was most abundant in kidney and exclusively present on the apical side of proximal tubules. Inhibition of megalin by antisense oligonucleotides (ASOs) led to ablation of AGT and renin proteins in proximal tubules, while leading to striking increases of urine AGT and renin concentrations, and 70% reduction of renal Ang II concentrations. However, plasma Ang II concentrations were unaffected. To determine whether AGT and megalin interaction contributes to atherosclerosis, we used both male and female low-density lipoprotein receptor-/- mice fed a saturated fat-enriched diet and administered vehicles (PBS or control ASO) or megalin ASO. Inhibition of megalin did not affect plasma cholesterol concentrations, but profoundly reduced atherosclerotic lesion size in both male and female mice. Conclusions- These results reveal a regulatory role of megalin in the intrarenal renin-angiotensin homeostasis and atherogenesis, positing renal Ang II to be an important contributor to atherosclerosis that is mediated through AGT and megalin interactions.Objective- AGT (Angiotensinogen) is the unique precursor of the renin-angiotensin system that is sequentially cleaved by renin and ACE (angiotensin-converting enzyme) to produce Ang II (angiotensin II). In this study, we determined how these renin-angiotensin components interact with megalin in kidney to promote atherosclerosis. Approach and Results- AGT, renin, ACE, and megalin were present in the renal proximal convoluted tubules of wild-type mice. Hepatocyte-specific AGT deficiency abolished AGT protein accumulation in proximal tubules and diminished Ang II concentrations in kidney, while renin was increased. Megalin was most abundant in kidney and exclusively present on the apical side of proximal tubules. Inhibition of megalin by antisense oligonucleotides (ASOs) led to ablation of AGT and renin proteins in proximal tubules, while leading to striking increases of urine AGT and renin concentrations, and 70% reduction of renal Ang II concentrations. However, plasma Ang II concentrations were unaffected. To determine whether AGT and megalin interaction contributes to atherosclerosis, we used both male and female low-density lipoprotein receptor-/- mice fed a saturated fat-enriched diet and administered vehicles (PBS or control ASO) or megalin ASO. Inhibition of megalin did not affect plasma cholesterol concentrations, but profoundly reduced atherosclerotic lesion size in both male and female mice. Conclusions- These results reveal a regulatory role of megalin in the intrarenal renin-angiotensin homeostasis and atherogenesis, positing renal Ang II to be an important contributor to atherosclerosis that is mediated through AGT and megalin interactions. Objective- AGT (Angiotensinogen) is the unique precursor of the renin-angiotensin system that is sequentially cleaved by renin and ACE (angiotensin-converting enzyme) to produce Ang II (angiotensin II). In this study, we determined how these renin-angiotensin components interact with megalin in kidney to promote atherosclerosis. Approach and Results- AGT, renin, ACE, and megalin were present in the renal proximal convoluted tubules of wild-type mice. Hepatocyte-specific AGT deficiency abolished AGT protein accumulation in proximal tubules and diminished Ang II concentrations in kidney, while renin was increased. Megalin was most abundant in kidney and exclusively present on the apical side of proximal tubules. Inhibition of megalin by antisense oligonucleotides (ASOs) led to ablation of AGT and renin proteins in proximal tubules, while leading to striking increases of urine AGT and renin concentrations, and 70% reduction of renal Ang II concentrations. However, plasma Ang II concentrations were unaffected. To determine whether AGT and megalin interaction contributes to atherosclerosis, we used both male and female low-density lipoprotein receptor mice fed a saturated fat-enriched diet and administered vehicles (PBS or control ASO) or megalin ASO. Inhibition of megalin did not affect plasma cholesterol concentrations, but profoundly reduced atherosclerotic lesion size in both male and female mice. Conclusions- These results reveal a regulatory role of megalin in the intrarenal renin-angiotensin homeostasis and atherogenesis, positing renal Ang II to be an important contributor to atherosclerosis that is mediated through AGT and megalin interactions. OBJECTIVE—AGT (Angiotensinogen) is the unique precursor of the renin-angiotensin system that is sequentially cleaved by renin and ACE (angiotensin-converting enzyme) to produce Ang II (angiotensin II). In this study, we determined how these renin-angiotensin components interact with megalin in kidney to promote atherosclerosis. APPROACH AND RESULTS—AGT, renin, ACE, and megalin were present in the renal proximal convoluted tubules of wild-type mice. Hepatocyte-specific AGT deficiency abolished AGT protein accumulation in proximal tubules and diminished Ang II concentrations in kidney, while renin was increased. Megalin was most abundant in kidney and exclusively present on the apical side of proximal tubules. Inhibition of megalin by antisense oligonucleotides (ASOs) led to ablation of AGT and renin proteins in proximal tubules, while leading to striking increases of urine AGT and renin concentrations, and 70% reduction of renal Ang II concentrations. However, plasma Ang II concentrations were unaffected. To determine whether AGT and megalin interaction contributes to atherosclerosis, we used both male and female low-density lipoprotein receptor mice fed a saturated fat-enriched diet and administered vehicles (PBS or control ASO) or megalin ASO. Inhibition of megalin did not affect plasma cholesterol concentrations, but profoundly reduced atherosclerotic lesion size in both male and female mice. CONCLUSIONS—These results reveal a regulatory role of megalin in the intrarenal renin-angiotensin homeostasis and atherogenesis, positing renal Ang II to be an important contributor to atherosclerosis that is mediated through AGT and megalin interactions. |
Author | Wu, Congqing Howatt, Deborah A. Ye, Feiming Wu, Chia-Hua Balakrishnan, Anju Graham, Mark J. Mullick, Adam E. Wang, Ya Danser, A.H. Jan Lu, Hong S. Daugherty, Alan Wang, Jian’an |
Author_xml | – sequence: 1 givenname: Feiming surname: Ye fullname: Ye, Feiming – sequence: 2 givenname: Ya surname: Wang fullname: Wang, Ya – sequence: 3 givenname: Congqing surname: Wu fullname: Wu, Congqing – sequence: 4 givenname: Deborah surname: Howatt middlename: A. fullname: Howatt, Deborah A. – sequence: 5 givenname: Chia-Hua surname: Wu fullname: Wu, Chia-Hua – sequence: 6 givenname: Anju surname: Balakrishnan fullname: Balakrishnan, Anju – sequence: 7 givenname: Adam surname: Mullick middlename: E. fullname: Mullick, Adam E. – sequence: 8 givenname: Mark surname: Graham middlename: J. fullname: Graham, Mark J. – sequence: 9 givenname: A.H. surname: Danser middlename: Jan fullname: Danser, A.H. Jan – sequence: 10 givenname: Jian’an surname: Wang fullname: Wang, Jian’an – sequence: 11 givenname: Alan surname: Daugherty fullname: Daugherty, Alan – sequence: 12 givenname: Hong surname: Lu middlename: S. fullname: Lu, Hong S. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30567480$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kctuFDEQRa0oiDzgB7JAvWTTiV_tx7IzIiRSIiSUsLU87uoZQ4892G5F7PIRfCFfgkcz2bBg4XJd6d6S6tQZOg4xAEIXBF8SIshV__jtur_tq1CXrBYij9Ap6ShvuWDiuPZY6rYTnJ6gs5y_Y4w5pfgtOmG4E5IrfIqe-rDysUDIPsQVhMaGoXmAlZ18aO5CgWRd8THkZhFDSX45F2hKbPqyhhSzm3bV5z8vv6-Th7H5CtuYyjv0ZrRThveH_xw93Xx6XNy2918-3y36-9bxTsnWSjwIazsNzlGJtcbaDm4gnCi91EKC0g5GNwqt-BJLR5yySgwCFKOsowM7Rx_3c7cp_pwhF7Px2cE02QBxzoaSTjPKleTV-uFgnZcbGMw2-Y1Nv8wrimpQe4OrG-UEo3G-2N3uJVk_GYLNjro5UK9CmT31GqX_RF-n_zfE96HnOFXM-cc0P0Mya7BTWZvdrZjAXUsx0ZhW2daHJfsLhm6WEQ |
CitedBy_id | crossref_primary_10_1161_ATVBAHA_121_315715 crossref_primary_10_1161_HYPERTENSIONAHA_119_12977 crossref_primary_10_1080_21655979_2021_1960463 crossref_primary_10_1161_ATVBAHA_124_321366 crossref_primary_10_1038_s41581_021_00414_6 crossref_primary_10_1161_HYPERTENSIONAHA_119_12873 crossref_primary_10_1016_j_lfs_2022_120923 crossref_primary_10_3389_fcvm_2023_1250234 crossref_primary_10_1016_j_phrs_2021_105922 crossref_primary_10_1161_HYPERTENSIONAHA_124_22806 crossref_primary_10_1097_MNH_0000000000000586 crossref_primary_10_3389_fendo_2021_738848 crossref_primary_10_1016_j_engreg_2024_06_002 crossref_primary_10_1161_HYPERTENSIONAHA_122_18731 crossref_primary_10_1161_ATVBAHA_124_318374 crossref_primary_10_1002_jcp_29889 crossref_primary_10_1124_pharmrev_120_000236 crossref_primary_10_1161_ATVBAHA_122_318930 crossref_primary_10_1016_j_phrs_2019_104537 crossref_primary_10_1016_j_ooc_2022_100022 crossref_primary_10_1186_s12944_021_01607_5 crossref_primary_10_1161_HYPERTENSIONAHA_119_12703 crossref_primary_10_1016_j_tvjl_2024_106287 crossref_primary_10_1089_jop_2022_0139 crossref_primary_10_1007_s11906_020_01037_1 crossref_primary_10_1016_j_peptides_2021_170714 crossref_primary_10_1016_j_peptides_2022_170770 crossref_primary_10_1161_ATVBAHA_120_313804 crossref_primary_10_1161_HYPERTENSIONAHA_120_14845 crossref_primary_10_1124_pr_118_017129 crossref_primary_10_1161_ATVBAHA_123_319897 crossref_primary_10_1016_j_ejim_2023_06_008 crossref_primary_10_1042_BSR20180201 crossref_primary_10_1007_s12013_024_01555_8 crossref_primary_10_1016_j_neo_2024_101009 crossref_primary_10_1016_j_jacbts_2021_04_004 crossref_primary_10_1159_000526369 crossref_primary_10_1161_JAHA_121_020467 crossref_primary_10_4103_jfmpc_jfmpc_989_24 crossref_primary_10_1016_j_exer_2019_05_020 crossref_primary_10_1016_j_biocel_2023_106393 crossref_primary_10_1111_bph_15955 crossref_primary_10_1161_ATVBAHA_120_314048 crossref_primary_10_3390_ijms22147407 crossref_primary_10_3390_jpm15010003 |
Cites_doi | 10.1126/science.2786251 10.1371/journal.pone.0051483 10.1681/ASN.2011121159 10.7156/v4i4p183 10.1152/ajprenal.00146.2007 10.1161/ATV.0000000000000062 10.1016/j.coph.2011.01.009 10.1016/j.kint.2015.11.007 10.1161/HYPERTENSIONAHA.115.05166 10.1056/NEJM199901143400207 10.1007/BF00583388 10.1681/ASN.2016070734 10.1084/jem.20070120 10.1038/nrm778 10.1038/35025203 10.1152/ajpcell.00287.2006 10.1152/ajpregu.00338.2012 10.1007/BF00537778 10.1161/ATVBAHA.117.309524 10.1074/jbc.275.1.5 10.1161/HYPERTENSIONAHA.115.07012 10.1172/JCI7818 10.1161/01.ATV.0000254680.71485.92 10.1152/ajprenal.00317.2005 10.1007/s11906-006-0040-9 10.1056/NEJMoa0801317 10.1073/pnas.91.21.9725 10.1161/ATVBAHA.107.152363 10.1159/000078716 10.1016/j.ejphar.2015.03.090 10.1172/JCI32970 10.1074/jbc.M110.150284 10.1007/BF01716726 10.1177/1753944715585512 10.1056/NEJM200001203420301 10.1046/j.1523-1755.2002.00155.x 10.1681/ASN.2012010078 10.1007/978-1-59745-571-8_4 10.1161/ATVBAHA.115.307038 10.1161/01.CIR.103.3.448 10.1161/01.HYP.33.1.340 10.1161/ATVBAHA.118.311282 10.1161/ATVBAHA.115.306740 10.1161/01.atv.0000021412.56621.a2 10.1016/S1357-2725(02)00178-4 10.1291/hypres.31.1791 10.1161/atvbaha.113.301777 10.1038/nature06796 10.1083/jcb.131.6.1609 10.1038/hr.2016.17 |
ContentType | Journal Article |
Copyright | 2019 American Heart Association, Inc. |
Copyright_xml | – notice: 2019 American Heart Association, Inc. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1161/ATVBAHA.118.311817 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1524-4636 |
EndPage | 155 |
ExternalDocumentID | 30567480 10_1161_ATVBAHA_118_311817 00043605-201902000-00007 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: NHLBI NIH HHS grantid: R01 HL139748 |
GroupedDBID | --- .3C .55 .GJ .Z2 01R 0R~ 1J1 23N 2WC 3O- 40H 4Q1 4Q2 4Q3 53G 5GY 5RE 5VS 71W 77Y 7O~ AAAAV AAAXR AAGIX AAHPQ AAIQE AAMOA AAMTA AAQKA AARTV AASCR AASOK AAXQO ABASU ABBUW ABDIG ABJNI ABPXF ABQRW ABVCZ ABXVJ ABZAD ABZZY ACCJW ACDDN ACEWG ACGFS ACGOD ACILI ACLDA ACPRK ACWDW ACWRI ACXJB ACXNZ ACZKN ADBBV ADFPA ADGGA ADHPY ADNKB AE3 AE6 AEETU AENEX AFBFQ AFDTB AFFNX AFUWQ AGINI AHJKT AHMBA AHOMT AHQNM AHRYX AHVBC AIJEX AINUH AJCLO AJIOK AJNWD AJNYG AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC AYCSE BAWUL BOYCO BQLVK BS7 C1A C45 CS3 DIK DIWNM DUNZO E.X E3Z EBS EEVPB EJD ERAAH EX3 F2K F2L F2M F2N F5P FCALG FL- FRP FW0 GNXGY GQDEL GX1 H0~ H13 HLJTE HZ~ IKREB IKYAY IN~ IPNFZ J5H JF9 JG8 JK3 JK8 K8S KD2 KMI KQ8 L-C L7B N9A N~7 N~B N~M O9- OAG OAH OB2 OCUKA ODA OL1 OLG OLH OLU OLV OLY OLZ OPUJH ORVUJ OUVQU OVD OVDNE OVIDH OVLEI OWU OWV OWW OWX OWY OWZ OXXIT P-K P2P PQQKQ PZZ RAH RIG RLZ S4R S4S T8P TEORI TR2 TSPGW V2I VVN W3M W8F WOQ WOW X3V X3W X7M XXN XYM YFH ZGI ZZMQN AAYXX ADGHP CITATION ACIJW CGR CUY CVF ECM EIF NPM 7X8 ADKSD ADSXY |
ID | FETCH-LOGICAL-c4587-a70d6aa59ecc2709909adcd14189b967e89cefcf6984b07c1c8a86d6e832352d3 |
ISSN | 1079-5642 1524-4636 |
IngestDate | Mon Sep 08 16:45:57 EDT 2025 Thu Apr 03 07:10:00 EDT 2025 Thu Apr 24 23:09:23 EDT 2025 Tue Jul 01 02:22:01 EDT 2025 Fri May 16 03:57:54 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | atherosclerosis angiotensinogen angiotensins mice renin |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c4587-a70d6aa59ecc2709909adcd14189b967e89cefcf6984b07c1c8a86d6e832352d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/6344256 |
PMID | 30567480 |
PQID | 2159324874 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_2159324874 pubmed_primary_30567480 crossref_citationtrail_10_1161_ATVBAHA_118_311817 crossref_primary_10_1161_ATVBAHA_118_311817 wolterskluwer_health_00043605-201902000-00007 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2019-February 2019-02-00 20190201 |
PublicationDateYYYYMMDD | 2019-02-01 |
PublicationDate_xml | – month: 02 year: 2019 text: 2019-February |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Arteriosclerosis, thrombosis, and vascular biology |
PublicationTitleAlternate | Arterioscler Thromb Vasc Biol |
PublicationYear | 2019 |
Publisher | American Heart Association, Inc |
Publisher_xml | – name: American Heart Association, Inc |
References | e_1_3_5_27_2 e_1_3_5_25_2 e_1_3_5_23_2 e_1_3_5_21_2 e_1_3_5_44_2 e_1_3_5_46_2 e_1_3_5_48_2 e_1_3_5_29_2 e_1_3_5_40_2 e_1_3_5_42_2 e_1_3_5_7_2 e_1_3_5_9_2 e_1_3_5_3_2 e_1_3_5_5_2 e_1_3_5_39_2 e_1_3_5_16_2 e_1_3_5_37_2 e_1_3_5_14_2 e_1_3_5_12_2 e_1_3_5_35_2 e_1_3_5_10_2 e_1_3_5_18_2 e_1_3_5_50_2 e_1_3_5_52_2 e_1_3_5_31_2 Bing J (e_1_3_5_33_2) 1972; 80 e_1_3_5_28_2 e_1_3_5_26_2 e_1_3_5_24_2 e_1_3_5_22_2 e_1_3_5_43_2 e_1_3_5_45_2 e_1_3_5_47_2 e_1_3_5_49_2 e_1_3_5_2_2 e_1_3_5_41_2 e_1_3_5_8_2 e_1_3_5_20_2 e_1_3_5_4_2 e_1_3_5_6_2 e_1_3_5_17_2 e_1_3_5_38_2 e_1_3_5_15_2 e_1_3_5_36_2 e_1_3_5_13_2 e_1_3_5_34_2 e_1_3_5_11_2 e_1_3_5_32_2 e_1_3_5_19_2 e_1_3_5_51_2 e_1_3_5_30_2 |
References_xml | – ident: e_1_3_5_21_2 doi: 10.1126/science.2786251 – ident: e_1_3_5_44_2 doi: 10.1371/journal.pone.0051483 – ident: e_1_3_5_20_2 doi: 10.1681/ASN.2011121159 – ident: e_1_3_5_5_2 doi: 10.7156/v4i4p183 – ident: e_1_3_5_14_2 doi: 10.1152/ajprenal.00146.2007 – ident: e_1_3_5_30_2 doi: 10.1161/ATV.0000000000000062 – ident: e_1_3_5_17_2 doi: 10.1016/j.coph.2011.01.009 – ident: e_1_3_5_25_2 doi: 10.1016/j.kint.2015.11.007 – ident: e_1_3_5_27_2 doi: 10.1161/HYPERTENSIONAHA.115.05166 – ident: e_1_3_5_35_2 doi: 10.1056/NEJM199901143400207 – ident: e_1_3_5_49_2 doi: 10.1007/BF00583388 – ident: e_1_3_5_18_2 doi: 10.1681/ASN.2016070734 – ident: e_1_3_5_34_2 doi: 10.1084/jem.20070120 – ident: e_1_3_5_23_2 doi: 10.1038/nrm778 – ident: e_1_3_5_37_2 doi: 10.1038/35025203 – ident: e_1_3_5_43_2 doi: 10.1152/ajpcell.00287.2006 – ident: e_1_3_5_16_2 doi: 10.1152/ajpregu.00338.2012 – ident: e_1_3_5_47_2 doi: 10.1007/BF00537778 – ident: e_1_3_5_29_2 doi: 10.1161/ATVBAHA.117.309524 – ident: e_1_3_5_46_2 doi: 10.1074/jbc.275.1.5 – ident: e_1_3_5_52_2 doi: 10.1161/HYPERTENSIONAHA.115.07012 – ident: e_1_3_5_9_2 doi: 10.1172/JCI7818 – ident: e_1_3_5_40_2 doi: 10.1161/01.ATV.0000254680.71485.92 – ident: e_1_3_5_15_2 doi: 10.1152/ajprenal.00317.2005 – ident: e_1_3_5_3_2 doi: 10.1007/s11906-006-0040-9 – ident: e_1_3_5_8_2 doi: 10.1056/NEJMoa0801317 – ident: e_1_3_5_22_2 doi: 10.1073/pnas.91.21.9725 – ident: e_1_3_5_42_2 doi: 10.1161/ATVBAHA.107.152363 – ident: e_1_3_5_13_2 doi: 10.1159/000078716 – ident: e_1_3_5_4_2 doi: 10.1016/j.ejphar.2015.03.090 – ident: e_1_3_5_38_2 doi: 10.1172/JCI32970 – ident: e_1_3_5_26_2 doi: 10.1074/jbc.M110.150284 – ident: e_1_3_5_48_2 doi: 10.1007/BF01716726 – ident: e_1_3_5_19_2 doi: 10.1177/1753944715585512 – ident: e_1_3_5_7_2 doi: 10.1056/NEJM200001203420301 – ident: e_1_3_5_45_2 doi: 10.1046/j.1523-1755.2002.00155.x – ident: e_1_3_5_50_2 doi: 10.1681/ASN.2012010078 – ident: e_1_3_5_31_2 doi: 10.1007/978-1-59745-571-8_4 – ident: e_1_3_5_6_2 doi: 10.1161/ATVBAHA.115.307038 – ident: e_1_3_5_10_2 doi: 10.1161/01.CIR.103.3.448 – ident: e_1_3_5_51_2 doi: 10.1161/01.HYP.33.1.340 – ident: e_1_3_5_11_2 doi: 10.1161/ATVBAHA.118.311282 – ident: e_1_3_5_28_2 doi: 10.1161/ATVBAHA.115.306740 – volume: 80 start-page: 646 year: 1972 ident: e_1_3_5_33_2 article-title: Relation between renin substrate and acute phase proteins. Studies of normal and adrenalectomized rats. publication-title: Acta Pathol Microbiol Scand A – ident: e_1_3_5_36_2 doi: 10.1161/01.atv.0000021412.56621.a2 – ident: e_1_3_5_12_2 doi: 10.1016/S1357-2725(02)00178-4 – ident: e_1_3_5_41_2 doi: 10.1291/hypres.31.1791 – ident: e_1_3_5_39_2 doi: 10.1161/atvbaha.113.301777 – ident: e_1_3_5_2_2 doi: 10.1038/nature06796 – ident: e_1_3_5_24_2 doi: 10.1083/jcb.131.6.1609 – ident: e_1_3_5_32_2 doi: 10.1038/hr.2016.17 |
SSID | ssj0004220 |
Score | 2.4873362 |
Snippet | OBJECTIVE—AGT (Angiotensinogen) is the unique precursor of the renin-angiotensin system that is sequentially cleaved by renin and ACE (angiotensin-converting... Objective- AGT (Angiotensinogen) is the unique precursor of the renin-angiotensin system that is sequentially cleaved by renin and ACE (angiotensin-converting... |
SourceID | proquest pubmed crossref wolterskluwer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 150 |
SubjectTerms | Angiotensin II - biosynthesis Angiotensinogen - physiology Animals Atherosclerosis - etiology Female Hypercholesterolemia - complications Low Density Lipoprotein Receptor-Related Protein-2 - antagonists & inhibitors Low Density Lipoprotein Receptor-Related Protein-2 - physiology Male Mice Mice, Inbred C57BL Oligonucleotides, Antisense - pharmacology Renin-Angiotensin System - physiology |
Title | Angiotensinogen and Megalin Interactions Contribute to Atherosclerosis—Brief Report |
URI | https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00043605-201902000-00007 https://www.ncbi.nlm.nih.gov/pubmed/30567480 https://www.proquest.com/docview/2159324874 |
Volume | 39 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3raxQxEA9aobSI-PZ8EcFvkrqPbJL9uBXlECqIV6mflmQ3dxza3da7Q_CvdybJPtqron4Jl93cLOQ3mcwk8yDkpYZdEXZpzkymDOMyE0wrblgqQJPjiZGJwmjkow9ieszfn2Qnw3WBiy5Zm4Pq55VxJf-DKjwDXDFK9h-Q7YnCA_gN-EILCEP7VxgXzWLZOhf0poVB3mnCgsxfhqM-H7XgynL6ylauUEaBSl-7AmLQLlfsEMzleVDFx8pqge6ey2EgwoFlFU5N18MP9r6sIZ_TcArrFGOLZcMWw7m9ly1fht1g485q22ZxPhqH3rz-2ioIxHDmGs4nMCSq9_WwQaYmnGFesrHQ9RmMAnMlIwka-zy025JdoGQvZp8Pi2kBXXWQYsysHA8GdM5OHdZoGEnua0RdyqfdvbpObiQS9C28yP84yjCfJFEXXCXi19sf3CO7HYmLusyWgbJPbv5o0edh9dWFPIwUl9ltcitYHLTw7HOHXLPNXbJ7FHwq7pFPl7iIAqg0cBEdcxEduIiuW3olF1HPRffJ8bu3szdTFkptsIpnsM1oGdVC6yyHFZ1IvCzNdV3VMY9VbnIhrcorO6_mIoeFHMkqrpRWohYWNgRQ4ev0Adlp2sY-IrRW3PK5NpGoQdXmQgugqlIrrAXrI7UTEneTVlYhDz2WQ_lWOntUxGWYc-io0s_5hLzq_3Pms7D8cfSLDosShCXegOnGtptVCfot2Ctgo_MJeehB6ul1oE4Iu4Ba6QOSS3dpDsY_QyaPuowMkXz8W0pPyN6wIJ6SnfX3jX0GKuzaPHc89wso25h1 |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Angiotensinogen+and+Megalin+Interactions+Contribute+to+Atherosclerosis-Brief+Report&rft.jtitle=Arteriosclerosis%2C+thrombosis%2C+and+vascular+biology&rft.au=Ye%2C+Feiming&rft.au=Wang%2C+Ya&rft.au=Wu%2C+Congqing&rft.au=Howatt%2C+Deborah+A&rft.date=2019-02-01&rft.eissn=1524-4636&rft.volume=39&rft.issue=2&rft.spage=150&rft_id=info:doi/10.1161%2FATVBAHA.118.311817&rft_id=info%3Apmid%2F30567480&rft.externalDocID=30567480 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1079-5642&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1079-5642&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1079-5642&client=summon |